Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture.

Biologically active human interleukin-2 (IL-2) and IL-4, key lymphokines involved in immune regulation, were produced and secreted into the medium by genetically modified Nicotiana tabacum cells grown in suspension culture. Secretion through the plasma membrane and cell wall into the medium was facilitated by the natural mammalian leader sequences. IL-2 and IL-4 were detected in the medium at concentrations of 0.10 and 0.18 microgram/mL, respectively, although higher levels were detected within the lymphokine-producing cells (approximately 0.80 microgram/mL for IL-2 and approximately 0.28 microgram/mL for IL-4). By Western blot, IL-4 was found to be secreted as two small polypeptides with molecular masses of approximately 18-20 kDa. The biological activity of IL-2 was determined by cell proliferation of the IL-2-dependent murine CTLL-2 cell line, while that of IL-4 was determined by cell proliferation of the CTLL-2 cell line [CT.h4S] which was stably transfected with the human IL-4 receptor. These findings indicate that plant suspension culture can be used to produce and secrete into the medium a variety of biologically active mammalian proteins that are of clinical and diagnostic relevance.

[1]  C. Potvin,et al.  Expression of active hen egg white lysozyme in transgenic tobacco , 1992 .

[2]  T. Hohn,et al.  The expression, localization, and effect of a human interferon in plants. , 1989, Virology.

[3]  J. Roth,et al.  Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial. , 1991, Cancer research.

[4]  M. Montagu,et al.  Enkephalins Prouduced in Transgenic Plants Using Modified 2S Seed Storage Proteins , 1989, Bio/Technology.

[5]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[6]  G. Crabtree,et al.  T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Hiatt,et al.  Production of antibodies in transgenic plants , 1989, Nature.

[8]  T. Taniguchi,et al.  Structure and expression of a cloned cDNA for human interleukin-2 , 1983, Nature.

[9]  P. Elzen,et al.  Production of Correctly Processed Human Serum Albumin in Transgenic Plants , 1990, Bio/Technology.

[10]  P. Doran,et al.  Production of monoclonal antibodies by tobacco hairy roots. , 1997, Biotechnology and bioengineering.

[11]  J. Coligan,et al.  High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4. , 1987, Journal of immunology.

[12]  G. Gros,et al.  Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. , 1993, Science.

[13]  J. Rubin,et al.  Interleukin-2: its biology and clinical application in patients with cancer. , 1993, Cancer investigation.

[14]  R. Nakagawa,et al.  Characterization of disulfide bonds in recombinant proteins: reduced human interleukin 2 in inclusion bodies and its oxidative refolding. , 1987, Biochemistry.

[15]  R. Coffman,et al.  A minority subpopulation of CD4+ T cells directs the development of naive CD4+ T cells into IL-4-secreting cells. , 1994, Journal of immunology.

[16]  T. Lehner,et al.  Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants , 1994, European journal of immunology.

[17]  R. Reeves,et al.  Enhanced recovery of a secreted mammalian protein from suspension culture of genetically modified tobacco cells. , 1996, Protein expression and purification.

[18]  T. Lehner,et al.  Generation and assembly of secretory antibodies in plants , 1995, Science.

[19]  C. Potvin,et al.  Secreted hen lysozyme in transgenic tobacco: recovery of bound enzyme and in vitro growth inhibition of plant pathogens , 1995 .

[20]  R. Schilperoort,et al.  Plant Molecular Biology Manual , 1989, Springer Netherlands.

[21]  K. Janda,et al.  Evaluation of Immunoglobulins from Plant Cells , 1991, Biotechnology progress.

[22]  K. HayGlass,et al.  Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. , 1995, Journal of immunological methods.

[23]  W. Paul,et al.  B-cell stimulatory factor-1/interleukin 4. , 1987, Annual review of immunology.

[24]  R. Sasaki,et al.  Expression of human erythropoietin in cultured tobacco cells. , 1993, Bioscience, biotechnology, and biochemistry.

[25]  W. Paul Interleukin-4: a prototypic immunoregulatory lymphokine. , 1991, Blood.

[26]  F. Skoog,et al.  A revised medium for rapid growth and bio assays with tobacco tissue cultures , 1962 .

[27]  W. Paul,et al.  Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). , 1989, Journal of immunology.

[28]  A. Levine,et al.  Disulfide assignments in recombinant mouse and human interleukin 4. , 1991, Biochemistry.

[29]  K. Arai,et al.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Coligan Current protocols in immunology , 1991 .